pocketful logo light
pocketful logo light
Global Health Ltd logo

Global Health Ltd

NSE: MEDANTA BSE: 543654

₹1240.40

(0.14%)

Thu, 18 Jun 2026, 06:16 pm

Global Health Enterprise Value (EV)

Particulars2018201920202021202220232024
Price to earnings ratio000041.8774.3566.85
Price to book ratio00005.8112.239.50
Price to sales ratio00005.0810.958.82
Price to cash flow ratio000022.1255.5748.35
Enterprise value000013495Cr35182Cr31781Cr
Enterprise value to EBITDA ratio000021.0142.5037.14
Debt to equity ratio0.610.690.670.690.460.280.21
Return on equity %02.752.1113.0916.1317.9315.30

Global Health Ltd Enterprise Value

The Global Health Ltd Enterprise Value is a key financial metric used by investors to evaluate Global Health Ltd's valuation, profitability, and overall financial performance. Tracking the Global Health Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Global Health Ltd (NSE: MEDANTA, BSE: 543654) is currently trading at ₹1240.40, with a market capitalization of ₹32606.94Cr. As a leading company in the Health services sector and Hospital/Nursing management industry, monitoring the Global Health Ltd Enterprise Value is essential for fundamental analysis.

Global Health Ltd Enterprise Value Current Value

The current Global Health Ltd Enterprise Value stands at 31781Cr.

The Global Health Ltd Enterprise Value has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.

Global Health Ltd Enterprise Value Historical Trend

The Global Health Ltd Enterprise Value has shown the following historical trend:

  • 2024: 31781Cr
  • 2023: 35182Cr
  • 2022: 13495Cr
  • 2021: 0
  • 2020: 0

The decline in Global Health Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.

What Global Health Ltd Enterprise Value Indicates for Investors

The Global Health Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Global Health Ltd.

Global Health Ltd Enterprise Value Analysis Summary

The Global Health Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Global Health Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Global Health Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account

Enter your phone number